Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
02/27/2007 | US7183323 Sodium channel modulators |
02/27/2007 | US7183292 Substituted pyrrolidine and related compounds |
02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
02/27/2007 | US7183276 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
02/22/2007 | WO2006093547A3 Novel lipoxygenase inhibitors |
02/22/2007 | WO2006002185A8 Chemical compounds |
02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
02/22/2007 | US20070043234 Use of functionalized onium salts as a soluble support for organic synthesis |
02/22/2007 | US20070043088 Process for preparing lacidipine |
02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
02/22/2007 | US20070042109 Conversion of amine- to carboxyl groups on solid surfaces |
02/22/2007 | US20070041899 Radiolabelled substrates |
02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
02/21/2007 | EP1754701A1 Sulfonyloxy derivatives |
02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
02/21/2007 | EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals |
02/21/2007 | EP1753722A2 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine |
02/21/2007 | EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
02/21/2007 | EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
02/21/2007 | CN1918261A Anthracene derivative host having ranges of dopants |
02/21/2007 | CN1918124A New pyridin-2-one compounds useful as inhibitors of thrombin |
02/21/2007 | CN1918123A Extractive of marasmius androsaceus, derivative of piperidone, and appliction for preparing medication of anti high blood pressure |
02/21/2007 | CN1918114A Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
02/21/2007 | CN1917873A Diurea derivatives |
02/21/2007 | CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition |
02/21/2007 | CN1915974A Method for splitting Amlodipine |
02/20/2007 | US7179922 Chemical compounds |
02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
02/20/2007 | US7179820 Administering to an animal having ocular hypertension a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester |
02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
02/20/2007 | US7179794 Antibiotics; bactericides |
02/20/2007 | CA2375225C Mutual salt of amlodipine and atorvastatin |
02/15/2007 | WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
02/15/2007 | WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
02/15/2007 | US20070037984 Biphenyl derivatives |
02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
02/15/2007 | US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
02/15/2007 | CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
02/14/2007 | EP1752449A1 Pharmaceutical coposition |
02/14/2007 | EP1444220B1 Compounds and method for the treatment of overactive bladder |
02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
02/14/2007 | CN1914196A 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
02/14/2007 | CN1914192A Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
02/14/2007 | CN1914152A New compounds, methods for their preparation and use thereof |
02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
02/14/2007 | CN1300112C Synthesis method of N-benzyl-4-piperidyl formaldehgde |
02/13/2007 | US7176950 Catalyst components, process for their preparation and their use as catalyst components in polymerization of olefins |
02/13/2007 | US7176318 Processes for the production of fexofenadine |
02/13/2007 | US7176316 Amino-piperidine derivatives |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176222 Contacting a base with an enantiomerically pure hydroxyl group containing compound, reacting the product with a nitro, fluoro-containing benzene compound, reducing the product to the corresponding amine |
02/13/2007 | US7176218 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
02/13/2007 | US7176210 Cannabinoid receptor ligands and uses thereof |
02/13/2007 | US7176204 Substituted carboxylic acid derivatives |
02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
02/13/2007 | US7175872 Food sweetness or saltiness enhancers; such as N(1-carboxyethyl)-6-hydroxymethyl-pyridinium-3-olate; synthesis from amino acid or peptide with furan derivative |
02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
02/08/2007 | WO2007016358A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
02/08/2007 | WO2007015805A1 1-amino linked compounds |
02/08/2007 | WO2007015668A1 New salt iii |
02/08/2007 | WO2007015667A1 New salt ii |
02/08/2007 | WO2007015666A1 New salt i |
02/08/2007 | WO2007015664A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
02/08/2007 | WO2007015588A1 Piperidine derivative as tachykinin receptor antagonist |
02/08/2007 | WO2007015567A1 Cyclic amine compound |
02/08/2007 | WO2007015052A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil |
02/08/2007 | US20070032656 Use of metal complex compounds as oxidation catalysts |
02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
02/08/2007 | US20070032524 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
02/08/2007 | US20070032523 Chemical compounds |
02/08/2007 | US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
02/08/2007 | US20070032475 Novel compounds useful for bradykinin B1 receptor antagonism |
02/08/2007 | CA2617406A1 New salt iii |
02/08/2007 | CA2617404A1 New salt ii |
02/08/2007 | CA2617403A1 New salt i |
02/08/2007 | CA2617256A1 Cyclic amine compound |
02/08/2007 | CA2617165A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil |
02/08/2007 | CA2617127A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
02/08/2007 | CA2616184A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
02/07/2007 | EP1749032A1 Alkoxyamines containing a radically polymerizable group |
02/07/2007 | EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
02/07/2007 | EP1748984A1 Piperidine derivatives as nk1 and nk3 antagonists |
02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
02/07/2007 | CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |